Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer
- PMID: 23300022
- PMCID: PMC3601549
- DOI: 10.1158/1055-9965.EPI-12-0794
Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer
Abstract
Background: Phenotypic biomarkers of DNA damage repair may enhance cancer risk prediction. The γ-H2AX formed at the sites of double-strand break (DSB) after ionizing radiation is a specific marker of DNA damage.
Methods: In an ongoing case-control study, the baseline and ionizing radiation-induced γ-H2AX levels in peripheral blood lymphocytes (PBL) from frequency-matched 306 untreated patients with lung cancer and 306 controls were measured by a laser scanning cytometer-based immunocytochemical method. The ratio of ionizing radiation-induced γ-H2AX level to the baseline was used to evaluate interindividual variation of DSB damage response and to assess the risk of lung cancer by using unconditional multivariable logistic regression with adjustment of age, sex, ethnicity, smoking status, family history of lung cancer, dust exposure, and emphysema.
Results: The mean γ-H2AX ratio was significantly higher in cases than controls (1.46 ± 0.14 vs. 1.41 ± 0.12, P < 0.001). Dichotomized at the median in controls, high γ-H2AX ratio was significantly associated with increased risk of lung cancer [OR = 2.43; 95% confidence interval (CI): 1.66-3.56]. There was also a significant dose-response relationship between γ-H2AX ratio and lung cancer risk in quartile analysis. Analysis of joint effects with other epidemiologic risk factors revealed elevated risk with increasing number of risk factors.
Conclusion: γ-H2AX activity as shown by measuring DSB damage in ionizing radiation-irradiated PBLs may be a novel phenotypic marker of lung cancer risk.
Impact: γ-H2AX assay is a robust and quantifiable image-based cytometer method that measures mutagen-induced DSB response in PBLs as a potential biomarker in lung cancer risk assessment.
Conflict of interest statement
No potential conflicts of interest were disclosed.
Figures

Similar articles
-
Measurement of DNA damage in peripheral blood by the γ-H2AX assay as predictor of colorectal cancer risk.DNA Repair (Amst). 2017 May;53:24-30. doi: 10.1016/j.dnarep.2017.03.001. Epub 2017 Mar 6. DNA Repair (Amst). 2017. PMID: 28291710
-
Risk assessment of esophageal adenocarcinoma using γ-H2AX assay.Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1797-804. doi: 10.1158/1055-9965.EPI-13-0485. Epub 2013 Jul 31. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23904462 Free PMC article.
-
γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer.Carcinogenesis. 2013 Nov;34(11):2543-7. doi: 10.1093/carcin/bgt270. Epub 2013 Aug 14. Carcinogenesis. 2013. PMID: 23946494 Free PMC article.
-
Evaluation of chemical phototoxicity, focusing on phosphorylated histone H2AX.J Radiat Res. 2015 Mar;56(2):220-8. doi: 10.1093/jrr/rru105. Epub 2014 Dec 4. J Radiat Res. 2015. PMID: 25480829 Free PMC article. Review.
-
Radiation Induced DNA Double-Strand Breaks in Radiology.Rofo. 2015 Oct;187(10):872-8. doi: 10.1055/s-0035-1553209. Epub 2015 Sep 2. Rofo. 2015. PMID: 26333102 Review.
Cited by
-
The role of Box A of HMGB1 in producing γH2AX associated DNA breaks in lung cancer.Sci Rep. 2025 Jan 25;15(1):3215. doi: 10.1038/s41598-025-87773-3. Sci Rep. 2025. PMID: 39863746 Free PMC article.
-
Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck--A case-control study.DNA Repair (Amst). 2016 Apr;40:18-26. doi: 10.1016/j.dnarep.2016.02.003. Epub 2016 Mar 2. DNA Repair (Amst). 2016. PMID: 26963119 Free PMC article.
-
CT Scanning: Is the Contrast Material Enhancing the Radiation Dose and Cancer Risk as Well as the Image?Radiology. 2015 Jun;275(3):627-9. doi: 10.1148/radiol.2015150605. Radiology. 2015. PMID: 25997129 Free PMC article.
-
Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment.Front Nucl Med. 2024 Oct 21;4:1469897. doi: 10.3389/fnume.2024.1469897. eCollection 2024. Front Nucl Med. 2024. PMID: 39498386 Free PMC article. Review.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Villeneuve PJ, Mao Y. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health. 1994;85:385–388. - PubMed
-
- Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer. 2008;123:1–7. - PubMed
-
- Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer. 1989;43:403–409. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical